AHA Science (@ahascience) 's Twitter Profile
AHA Science

@ahascience

@American_Heart’s official account for meetings, science news, funding opportunities and membership. RTs/Follows not endorsements. Pump up your career, here.

ID: 19596228

linkhttps://professional.heart.org/ calendar_today27-01-2009 15:17:07

12,12K Tweet

72,72K Followers

4,4K Following

AHA Science (@ahascience) 's Twitter Profile Photo
AHA Science
@ahascience

a year ago

Nex-z results presented at #AHA24 In patients w/ ATTR-CM, the CRISPR-based therapy nexiguran ziclumeran (nex-z) reduced serum TTR levels, limited disease progression, and improved functional capacity, highlighting its potential to have a favorable impact on disease progression.

Nex-z results presented at #AHA24 In patients w/ ATTR-CM, the CRISPR-based therapy nexiguran ziclumeran (nex-z) reduced serum TTR levels, limited disease progression, and improved functional capacity, highlighting its potential to have a favorable impact on disease progression.